Julie Abildgaard1, Jeanette Tingstedt2,3, Yanan Zhao2, Hans Jakob Hartling2, Anette Tønnes Pedersen4, Birgitte Lindegaard1,5, Susanne Dam Nielsen2. 1. The Centre of Inflammation and Metabolism and the Centre for Physical Activity Research, Rigshospitalet, University of Copenhagen, København Ø, Denmark. 2. Viro-immunology Research Unit, Department of infectious diseases, Rigshospitalet, University of Copenhagen, København Ø, Denmark. 3. Virus Research and Development, Department of Virology and Special Microbial Diagnostic, Statens Serum Institut, København Ø, Denmark. 4. Department of Gynaecology, Rigshospitalet, University of Copenhagen, København Ø, Denmark. 5. Department of Pulmonary and Infectious Diseases, Nordsjællands Hospital, Hillerød, Denmark.
Abstract
AIM: To investigate markers of systemic inflammation in pre- and postmenopausal women and identify possible predictors of systemic inflammation with menopause. METHODS: Cross-sectional study of 69 healthy women between 45- and 60 years. Blood samples were collected to assess leukocyte subsets and plasma cytokines. MRI and DXA scans were performed to assess body composition. Through uni- and multivariate analyses, follicle-stimulating hormone (FSH), visceral fat mass and age were evaluated as predictors of systemic inflammation in relation to menopause. RESULTS: Postmenopausal women tended to have higher leukocyte counts (5.4 x109 vs. 4.9 x109 cells/l, p = 0.05) reflected in increased total lymphocytes (1.8 x109 vs. 1.6 x109 cells/l, p = 0.01) and monocytes (0.5 x109 vs. 0.4 x109 cells/l, p = 0.02), compared to premenopausal women. Increased visceral fat mass was a strong predictor of high leukocyte subsets. Postmenopausal women had higher plasma TNF-α (2.24 vs. 1.91 pg/ml, p = 0.01) and IL-6 (0.45 vs. 0.33 pg/ml, p = 0.004) compared to premenopausal women and high FSH was a significant predictor of increased plasma TNF-α, IL-1β and IL-6. Menopause was further associated with increased T-cells (1,336 vs. 1,128 cells/μl, p = 0.04) reflected in significantly higher counts of exhausted-, senescent-, and memory CD4+ T-cell subsets. CONCLUSIONS: Menopause is associated with increased systemic inflammation as well as exhausted- and senescent T-cells. We suggest, that both increased visceral fat mass and declining sex hormone levels might contribute to postmenopausal systemic inflammation and calls for further large-scale studies to confirm these findings.
AIM: To investigate markers of systemic inflammation in pre- and postmenopausal women and identify possible predictors of systemic inflammation with menopause. METHODS: Cross-sectional study of 69 healthy women between 45- and 60 years. Blood samples were collected to assess leukocyte subsets and plasma cytokines. MRI and DXA scans were performed to assess body composition. Through uni- and multivariate analyses, follicle-stimulating hormone (FSH), visceral fat mass and age were evaluated as predictors of systemic inflammation in relation to menopause. RESULTS: Postmenopausal women tended to have higher leukocyte counts (5.4 x109 vs. 4.9 x109 cells/l, p = 0.05) reflected in increased total lymphocytes (1.8 x109 vs. 1.6 x109 cells/l, p = 0.01) and monocytes (0.5 x109 vs. 0.4 x109 cells/l, p = 0.02), compared to premenopausal women. Increased visceral fat mass was a strong predictor of high leukocyte subsets. Postmenopausal women had higher plasma TNF-α (2.24 vs. 1.91 pg/ml, p = 0.01) and IL-6 (0.45 vs. 0.33 pg/ml, p = 0.004) compared to premenopausal women and high FSH was a significant predictor of increased plasma TNF-α, IL-1β and IL-6. Menopause was further associated with increased T-cells (1,336 vs. 1,128 cells/μl, p = 0.04) reflected in significantly higher counts of exhausted-, senescent-, and memory CD4+ T-cell subsets. CONCLUSIONS: Menopause is associated with increased systemic inflammation as well as exhausted- and senescent T-cells. We suggest, that both increased visceral fat mass and declining sex hormone levels might contribute to postmenopausal systemic inflammation and calls for further large-scale studies to confirm these findings.
Authors: Lindsay D Strehle; Kathryn L G Russart; Valerie A Burch; Corena V Grant; Leah M Pyter Journal: Am J Physiol Regul Integr Comp Physiol Date: 2022-08-22 Impact factor: 3.210
Authors: Elizabeth B Engler-Chiurazzi; Wesley H Chastain; Kailen K Citron; Lillian E Lambert; Divya N Kikkeri; Sharhana S Shrestha Journal: Front Behav Neurosci Date: 2022-04-15 Impact factor: 3.617
Authors: Melanie R Kuhn; Melanie Haffner-Luntzer; Elena Kempter; Stefan O Reber; Hiroshi Ichinose; Jean Vacher; Anita Ignatius; Miriam E A Tschaffon-Müller Journal: Front Endocrinol (Lausanne) Date: 2022-09-15 Impact factor: 6.055